Major US Patent Granted
...“Agents Comprising Midkine or an Inhibitor Thereof as Active Ingredient”...
MTY Shareholder News October 2008
MTY Shareholder News
Convertible Notes Resolved
MTY has finalised an agreement with holders of MTY Convertible Notes ...
Analyst Report and Interactive Roadshow Released
... first online Interactive Investor Roadshow eKit ...
Midkine Test Validated
... Revenue Generating Veterinary Midkine Test Validated....
Midkine Strategy
...MTY completed its Midkine Commercial Developement Strategy...
Results of General Meeting 5 May 2009
Results of General Meeting of Members ...
Removal of $1.5M potential liability
MTY and Cell Signals Inc., have signed an amendment to the IP Agreement


Cellmid Ltd (CDY):

Last Price

Join Our Mailing List

We invite you to join our mailing list to receive our announcements electronically. To join, simply complete the form below:

Salutation
First Name
Last Name
Email Address
Reason for Interest
If Other Please Specify
© Cellmid Ltd
Share Trading Policy | Privacy | Contact Us
Web Developer Sydney
 Web design company
Cellmid Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@cellmid.com.au